Cherry Creek Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Buy
772
+13
+2% +$4.45K 0.11% 104
2026
Q1
$267K Buy
759
+10
+1% +$3.56K 0.12% 95
2025
Q4
$245K Buy
749
+3
+0.4% +$952 0.1% 101
2025
Q3
$211K Buy
+746
New +$216K 0.09% 107
2024
Q4
Sell
-778
Closed -$251K 111
2024
Q3
$251K Buy
778
+3
+0.4% +$981 0.13% 89
2024
Q2
$242K Sell
775
-74
-9% -$21.7K 0.13% 91
2024
Q1
$241K Sell
849
-97
-10% -$28.4K 0.13% 91
2023
Q4
$272K Buy
946
+4
+0.4% +$1.09K 0.17% 79
2023
Q3
$253K Buy
942
+2
+0.2% +$499 0.17% 72
2023
Q2
$209K Buy
940
+5
+0.5% +$1.16K 0.14% 84
2023
Q1
$226K Buy
935
+3
+0.3% +$736 0.17% 79
2022
Q4
$245K Sell
932
-56
-6% -$15K 0.19% 75
2022
Q3
$223K Buy
988
+3
+0.3% +$727 0.18% 79
2022
Q2
$240K Buy
985
+4
+0.4% +$980 0.19% 78
2022
Q1
$237K Buy
981
+3
+0.3% +$689 0.16% 91
2021
Q4
$220K Buy
+978
New +$206K 0.14% 102

Other funds holding AMGN

Cherry Creek Investment Advisors's AMGN Position: Q2 2026 in Review

Cherry Creek Investment Advisors increased its Amgen (AMGN) stake by 1.7% in Q2 2026, buying an estimated $4.45K and bringing the position to 772 shares worth $280K. The position accounts for 0.11% of the portfolio, ranked #104.

Cherry Creek Investment Advisors first reported a position in AMGN in Q4 2021 and has held it in 16 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cherry Creek Investment Advisors held 772 shares of Amgen worth $280K as of Q2 2026.
  • Cherry Creek Investment Advisors bought 13 Amgen shares in Q2 2026, an estimated $4.45K.
  • Amgen made up 0.11% of Cherry Creek Investment Advisors's portfolio in Q2 2026, its #104 holding.
  • Cherry Creek Investment Advisors first reported a position in Amgen in Q4 2021 and has held it in 16 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.